Cardiovascular Pathology - Hardcover

Über die Autorinnen und Autoren

Professor of Pathology and Laboratory Medicine, Medical School, The University of Texas Health Science Center at Houston (UTHealth); Distinguished Teaching Professor, The University of Texas System; Executive Director, The TMC Library; Editor-in-Chief, Cardiovascular Pathology (the official journal of the Society for Cardiovscular Pathology)

Dr. Buja MD is a Professor of Pathology and Laboratory Medicine at the University of Texas Health Science Center at Houston. His subspecialty interest is cardiovascular pathology with research interests in myocardial cell injury, myocardial ischemia, atherosclerosis and cardiomyopathies. Dr. Buja teaches medical students, medical residents, clinical fellows, graduate students and research post-doctoral fellows. He also conducts a clinical practice in cardiovascular pathology providing staffing of autopsy cases and surgical pathology consultation of cardiac and vascular cases and interpretation of myocardial biopsies from referrals. He directs a cardiovascular pathology fellowship approved by the Texas Medical Board. He is the editor-in-chief of Cardiovascular Pathology, the official journal of the Society for Cardiovascular Pathology. He also serves as the Executive Director of The Texas Medical Center Library located adjacent to the medical school.

Consultant Cardiovascular Pathologist/Director Autopsy Services Co-Editor-in-Chief, Cardiovascular Pathology, Guest Editor, Seminars in Diagnostic Pathology Secretary-Treasurer, WASPaLM, Professor, University of Toronto & Director, Division of Pathology,Dept. of Laboratory Medicine and Pathobiology, University Health Network / Laboratory Medicine Program Toronto General Hospital,Toronto, Ontario, Canada.

Dr. Butany is Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto, Canada and Director of the Division of Pathology in the Department. He is a Staff Cardiovascular Pathologist at the University Health Network (Toronto General Hospital Site), and Director of Autopsy Services. His investigative work has primarily been based on clinical investigations and outcomes and collaboration with clinical colleagues in basic and applied research. His major interest has been prosthetic heart valves. Dr. Butany has been involved in teaching at the undergraduate and post-graduate levels, including medical students, pathology residents, cardiology residents and cardiac surgery residents and fellows. He is a founding member of the Society for Cardiovascular Pathology and served as the president from 2007-2009). He has been Co-Editor-in-Chief of Cardiovascular Pathology, the official journal of the Society of Cardiovascular Pathology and continues to serve on its Editorial Board.

Von der hinteren Coverseite

Cardiovascular Pathology, Fifth Edition provides a comprehensive and contemporary treatise on the pathology of cardiovascular diseases, combining presentations of detailed pathology of cardiovascular diseases coupled with discussions of contemporary insights into the etiology and pathogenesis of these conditions. Twenty-two chapters cover general topics, including cardiovascular genetics, heart failure, and transplantation, and specific congenital and acquired cardiovascular diseases, therapeutic interventions, and forensic aspects. New chapters address the scope of practice and training in cardiovascular pathology, with a focus on major diagnostic approaches used in contemporary practice and research in cardiovascular pathology, and a perspective on the field of cardiovascular regenerative medicine linked to the basic pathobiology of cell-based therapy.

Cardiovascular Pathology provides a unique combination of details of pathological anatomy essential for pathologists involved in the evaluation of cardiovascular specimens and cardiovascular diseases, and is an excellent reference for anyone interested in the natural history and therapeutic advances in the cardiovascular field. The book’s content makes clear that cardiovascular pathologists will continue to have an important role in defining the impact of new therapeutic approaches on the outcomes of patients with cardiovascular diseases.